Related references
Note: Only part of the references are listed.Once-yearly zoledronic acid and change in abdominal aortic calcification over 3 years in postmenopausal women with osteoporosis: results from the HORIZON Pivotal Fracture Trial
G. Cai et al.
OSTEOPOROSIS INTERNATIONAL (2020)
Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton
Michael J. Rogers et al.
BONE (2020)
Relationship of coronary artery calcification with renal function decline and mortality in predialysis chronic kidney disease patients
Michelle C. Lamarche et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Clinical Guidelines and PTH Measurement: Does Assay Generation Matter?
Marjon A. Smit et al.
ENDOCRINE REVIEWS (2019)
Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study
Marta Cano-Megias et al.
BMC NEPHROLOGY (2019)
Pharmacology of bisphosphonates
Serge Cremers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Role of Klotho in bone and implication for CKD
Hirotaka Komaba et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy
Syazrah Salam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
PiT-2, a type III sodium-dependent phosphate transporter, protects against vascular calcification in mice with chronic kidney disease fed a high-phosphate diet
Shunsuke Yamada et al.
KIDNEY INTERNATIONAL (2018)
Cardiovascular disease in dialysis patients
Mario Cozzolino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
CKD, arterial calcification, atherosclerosis and bone health: Interrelationships and controversies
Allison B. Reiss et al.
ATHEROSCLEROSIS (2018)
Update on the role of bone biopsy in the management of patients with CKD-MBD
P. Evenepoel et al.
JOURNAL OF NEPHROLOGY (2017)
Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies
Carla Caffarelli et al.
CLINICAL INTERVENTIONS IN AGING (2017)
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Shunsuke Yamada et al.
BONE (2017)
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease
Xiang Lu et al.
KIDNEY DISEASES (2017)
FGF23-αKlotho as a paradigm for a kidney-bone network
Makoto Kuro-o et al.
BONE (2017)
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology
Keith A. Hruska et al.
BONE (2017)
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Wei Lv et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
The WNT system: background and its role in bone
U. H. Lerner et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
Marion Morena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Importance of Vascular Calcification Kidney Transplant Recipients
Giuseppe Cianciolo et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Bisphosphonate-osteoclasts: Changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients
Bjorn Jobke et al.
BONE (2014)
Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women
S. Gonnelli et al.
BONE (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
CKD-Induced Wingless/Integration1 Inhibitors and Phosphorus Cause the CKD-Mineral and Bone Disorder
Yifu Fang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
Yifu Fang et al.
KIDNEY INTERNATIONAL (2014)
Vascular calcification in long-term kidney transplantation
Kotcharat Vipattawat et al.
NEPHROLOGY (2014)
CKD-Mineral and Bone Disorder and Risk of Death and Cardiovascular Hospitalization in Patients on Hemodialysis
Geoffrey A. Block et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Renal Safety in Patients Treated With Bisphosphonates for Osteoporosis: A Review
Paul D. Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Bisphosphonate therapy in renal osteodystrophy - a review
Raoul Bergner
JOURNAL OF NEPHROLOGY (2013)
Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study
Ivana Pavik et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Aortic valve calcification in chronic kidney disease
Marcello Rattazzi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study
James E. Hartle et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability
Teresita Bellido et al.
BONE (2011)
Bisphosphonates: The first 40 years
R. Graham G. Russell
BONE (2011)
Steady state pharmacokinetics and dose equivalents of oral clodronate in renal failure
S. Makela et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2011)
The link between bone and coronary calcifications in CKD-5 patients on haemodialysis
Gulay Asci et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled Trial
Nigel D. Toussaint et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Retention of etidronate in human, dog, and rat
Gerald B. Kasting et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The emerging role of phosphate in vascular calcification
Cecilia M. Giachelli
KIDNEY INTERNATIONAL (2009)
Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
Minerva Rodriguez-Garcia et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Association of Changes in Bone Remodeling and Coronary Calcification in Hemodialysis Patients: A Prospective Study
Daniela Veit Barreto et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
Lilian I. Plotkin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
Nigel D. Toussain et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Vascular calcification and arterial stiffness in chronic kidney disease: Implications and management
Nigel D. Toussaint et al.
NEPHROLOGY (2007)
The Wnt signaling pathway and bone metabolism
Mark L. Johnson et al.
CURRENT OPINION IN RHEUMATOLOGY (2007)
Alendronate treatment in women with normal to severely impaired renal function: An analysis of the fracture intervention trial
Sophie A. Jamal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Prevention of aortic calcification by etidronate in the renal failure rat model
Kazuhiro Tamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
G. H. Nancollas et al.
BONE (2006)
Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: Long-term effects
H Hashiba et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2006)
Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO)
S. Moe et al.
KIDNEY INTERNATIONAL (2006)
Effect of etidronic acid on arterial calcification in dialysis patients
Tsuneo Ariyoshi et al.
CLINICAL DRUG INVESTIGATION (2006)
Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: A pooled analysis of nine clinical trials
PD Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Effect of etidronate on aortic calcification and bone metabolism in calcitoriol-treated rats with subtotal nephrectomy
K Tamura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation
KES Poole et al.
FASEB JOURNAL (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Discovery, clinical development, and therapeutic uses of bisphosphonates
AA Licata
ANNALS OF PHARMACOTHERAPY (2005)
Mechanisms of vascular calcification in uremia
CM Giachelli
SEMINARS IN NEPHROLOGY (2004)
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
H Yang et al.
KIDNEY INTERNATIONAL (2004)
The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)
BQ Pan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Wnt signaling in osteoblasts and bone diseases
JJ Westendorf et al.
GENE (2004)
Valvular and perivalvular abnormalities in end-stage renal disease
E Umana et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
Highly potent geminal bisphosphonates.: From pamidronate disodium (Aredia) to zoledronic acid (Zometa)
L Widler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
